Electrical Stimulation and Electromagnetic Therapy for Wound Treatments
Defines BCBSRI coverage stance for electrical stimulation and electromagnetic therapy for wound care in Commercial Products, including which modalities and HCPCS codes are considered not medically necessary. Applies to providers treating members under commercial plans.
No material clinical or coverage changes in this revision.
Coverage Determinations
Not Medically Necessary / Not Reimbursed
Coverage determination for Commercial Products:
Evidence insufficient to determine effects on health outcomes
For Commercial Products, electrical stimulation performed by individuals in the home setting for the treatment of wounds and electromagnetic therapy for the treatment of wounds are considered not medically necessary. The policy identifies these modalities specifically because the evidence is insufficient to determine that they improve health outcomes for wound care.
Claims for these modalities may be denied when billed for Commercial members. The policy further lists specific HCPCS codes that reflect these services: G0281, G0282, G0295, and G0329 are identified as not medically necessary, and device codes E0761 and E0769 are listed as not separately reimbursed. Providers should verify member benefits before delivering or billing these services.
Coding and Reimbursement
| G0281 | Electrical stimulation (unattended) to one or more areas for chronic stage III and stage IV pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care, as part of a therapy plan of care |
| G0282 | Electrical stimulation (unattended), to one or more areas, for wound care other than described in G0281 |
| G0295 | Electromagnetic therapy to one or more areas, for wound care other than described in G0329 or for other uses |
| G0329 | Electromagnetic therapy to one or more areas for chronic stage III and stage IV pressure ulcers, arterial ulcers, diabetic ulcers and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care, as part of a therapy plan of care |
Provider Responsibilities and Billing Alerts
Prior Authorization
Prior authorization is not required for electrical stimulation or electromagnetic therapy for wound treatment under this policy.
- Providers should verify member-specific benefits and prior auth requirements as contracts may vary.
Benefit Variability
Benefits may vary by contract. Always refer to the member's Evidence of Coverage, Benefit Booklet, or Subscriber Agreement for applicable coverage and non-covered benefits.
Benefit Verification and Member-Specific Coverage
Verify member eligibility and benefits before rendering services. Follow the member-specific Evidence of Coverage and subscriber documents to determine coverage, cost sharing, and any applicable prior authorization requirements.
Denial Triggers / Billing Alerts
Claims for home use electrical stimulation and the listed HCPCS codes will be denied / not reimbursed. The following HCPCS codes are not medically necessary or not separately reimbursed and should not be billed for coverage: G0281, G0282, G0295, G0329. The following HCPCS codes are not separately reimbursed: E0761, E0769.
Background and Rationale
Electrical stimulation (also called electrostimulation) involves applying electrical current via electrodes placed on or near a wound and has been used since the 1950s to attempt to promote wound healing through mechanisms such as stimulating cellular activity and improving blood flow. Electromagnetic therapy is a related but distinct approach that applies electromagnetic fields rather than direct electrical current. While some studies report intermediate improvements (for example, reductions in wound size), the overall evidence remains insufficient to establish consistent improvements in final health outcomes such as complete wound healing for the modalities described in this policy.
Key Definitions
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.